Follow Tom On:
Categories
-
Recent Posts
- The Business Of Healthcare: “Integrative Ketogenic Research And Therapeutics”
- Linking To And Embedding EM Note’s “Acute Bronchiolitis”
- Better? Worse? Or The Same?: “WHO Disability Assessment Schedule (WHODAS 2.0)”
- Linking To The Results Of A Google Search: The Global Assessment Of Functioning With An Additional Link To WHODAS 2.0
- Linking To And Embedding Metabolic Mind’s CME “Cardiovascular Safety Of Ketogenic Therapy”
- Google Search Results: “HOMA-IR (Homeostasis Model Assessment of Insulin Resistance)”
- Linking To And Embedding Metabolic Mind CME’s “The Evidence Supporting Ketogenic Therapy for the Treatment of Serious Mental Illness”
- Linking To And Excerpting From Diabetes Research And Clinical Practice’s “5-Year effects of a novel continuous remote care model with carbohydrate-restricted nutrition therapy including nutritional ketosis in type 2 diabetes: An extension study”
- Linking To The All ARUP Consult Genetics Content
- Linking To The ARUP Consult Test Fact Sheets
- Linking To The ARUP Consult Topics
- Linking To The ARUP Consult Testing Algorithms
- Exploring ARUP Laboratories’ Outstanding Clinical Resources
- Linking To And Embedding CessSim’s “How I Would Start Flight Simming After 50 Without Spending Heaps!”
- Linking To And Embedding Dr. Nick Norwitz’s “Why I’m Not Afraid of Alzheimer’s Anymore”
- Linking To And Excerprting From CoreIM’s “Lp(a) and ASCVD Risk: 5 Pearls Segment”
- Linking To, Embedding, And Excerpting From Dr. Nick Norwitz’ “Lp(a) Explained: Genetics, Risk, and What You Can Actually Do”
- Linking To And Embedding Dr. Nick Norwitz’s “Glucose Game-Changer: 5-Year Study Proves Remission is Possible”
- Linking To And Excerpting From Circulation’s “Apolipoprotein B: Bridging the Gap Between Evidence and Clinical Practice”
- Linking To And Embedding Dr. Nick Norwitz’s “Glucose Game-Changer: 5-Year Study Proves Remission is Possible”
- Linking To And Embedding Dr. Nick Norwitz’s “Better Than Statins? The Truth About the New Cholesterol Drug” [The PCSK9 Inhibitor Evolocumab (Repatha)
- Linking To, Embedding, And Excerpting From Metabolic Mind’s “ApoB Explained: What Your LDL Test Doesn’t Tell You” With Additional Resources
- Linking To And Excerpting From The European Journal Of Pediatrics’ “Point‑of‑care ultrasound (POCUS) protocol for systematic assessment of the crashing neonate—expert consensus statement of the international crashing neonate working group”
- Linking To And Exploring The HealthMeasures Website: “Transforming How Health Is Measured”
- Results of Google Search “Patient-Reported Outcome Measures (PROMs)”
- Linking To And Embedding Encephalitis International’s “Diagnosis and misdiagnosis of autoimmune encephalitis with Professor Irani”
- Linking To And Embedding Core IM’s “Imaging for Acute Cholecystitis: ultrasound vs MRCP vs. CT vs. HIDA”
- Linking To And Embedding National Neonatal POCUS Collaborative’s “Raising the Bar: Training and QA Framework for Safe Neonatal Ultrasound Practice – NPC Webinar”
- Linking To And Embedding NeoCardio Lab’s “Delphi 2024 Crashing Neonate POCUS workshop by Dr Lauren Ruoss”
- Linking To And Embedding National Neonatal POCUS Collaborative’s “Targeted Use of POCUS for a Crashing Infant in the NICU: SAFE-R Protocol”
Category Archives: Heart Failure
Links To And Excerpts From “The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial” From Nature
In this post I link to and excerpt from the Nature Medicine article, The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial [PubMed Abstract] [Full-Text HTML] [Full-Text PDF], Nat Med. 2021 Nov;27(11):1954-1960. All that … Continue reading
Posted in Heart Failure
Comments Off on Links To And Excerpts From “The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial” From Nature